{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:47:24Z","timestamp":1793141244564,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a multisystem autoimmune disease with small-vessel involvement. In AAV, microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are major clinicopathologic variants. In addition, myeloperoxidase (MPO) and proteinase 3 (PR3) are major target antigens. The objective of the study was to explore the predictive factors for long-term survival in AAV patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A multicenter retrospective study was carried out on 407 patients between 2005 and 2020. Clinical parameters were obtained from laboratory tests including the ANCA types, antinuclear antibody (ANA), extractable nuclear antigen (ENA), anti-streptolysin O (ASO), glomerular filtration rate (GFR), and the laboratory examinations for the blood routine, liver function, renal function, and immunity, etc. The data for clinical parameters were collected from electronic medical records (EMRs), and the data for patient survival were acquired through regular follow-up. The association of clinical parameters with overall survival (OS) along with 3-year and 5-year survival rates was analyzed, and the nomogram as a predictive model was established according to the analysis results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the present study, 336 (82.6%) patients and 46 (11.3%) patients were diagnosed with MPA and GPA, respectively. The mean and median OS for all the patients were 2,285 and 2,290 days, respectively. The 1-year, 3-year, 5-year, and 10-year cumulative survival rates for all the patients were 84.2%, 76.3%, 57.2%, and 32.4%, respectively. Univariate and multivariate survival analyses indicated that the independent prognostic factors included age, pathological categories (MPA, GPA, and other types), serum ANCA types (negative or positive for MPO and\/or PR3), ANA, ASO, GFR, lymphocyte, neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP), and these clinical parameters except for ASO were used to construct a nomogram. The nomogram for 3-year and 5-year survival rates had a C-index of 0.721 (95% CI 0.676\u20130.766). The calibration curves showed that the predicted values of the nomogram for 3-year and 5-year survival rates were generally consistent with practical observed values, and decision curve analysis (DCA) further demonstrated the practicability and accuracy of the predictive model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Laboratory tests at diagnosis have great significance in the prediction of long-term survival in AAV patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.913667","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T05:03:10Z","timestamp":1656565390000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Qian-Qian","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ju","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Zheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-Ni","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-1-60","article-title":"ANCA-Associated Vasculitis","volume":"17","author":"Yates","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00628-9","article-title":"Update on ANCA-Associated Vasculitis: From Biomarkers to Therapy","volume":"32","author":"Tedesco","year":"2019","journal-title":"J Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv022","article-title":"Classification, Epidemiology and Clinical Subgrouping of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","author":"Watts","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01461005","article-title":"Incidence of ANCA-Associated Primary Renal Vasculitis in the Miyazaki Prefecture: The First Population-Based, Retrospective, Epidemiologic Survey in Japan","volume":"1","author":"Fujimoto","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the Anca-Associated Vasculitides: Long-Term Data From the European Vasculitis Study Group (EUVAS) Therapeutic Trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs428","article-title":"Improved Outcome in Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis: A 30-Year Follow-Up Study","volume":"28","author":"Hilhorst","year":"2012","journal-title":"Nephrol Dialysis Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.02.002","article-title":"Granulomatosis With Polyangiitis: Study of 795 Patients From the French Vasculitis Study Group Registry","volume":"51","author":"Iudici","year":"2021","journal-title":"Semin Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778","article-title":"Long-Term Patient Survival in ANCA-Associated Vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"102338","DOI":"10.1016\/j.jaut.2019.102338","article-title":"Usual Interstitial Pneumonia in ANCA-Associated Vasculitis: A Poor Prognostic Factor","volume":"106","author":"Maillet","year":"2020","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11255-016-1419-4","article-title":"Therapy and Prognosis of ANCA-Associated Vasculitis From the Clinical Nephrologist's Perspective","volume":"49","author":"Haris","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13422","article-title":"Antineutrophilic Cytoplasmic Antibody-Associated Vasculitis With and Without Renal Involvement: C3 Contributes to Prognosis, But Renal Involvement Does Not","volume":"22","author":"Fukui","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5306","article-title":"Serum Creatinine Level and ESR Values Associated to Clinical Pathology Types and Prognosis of Patients With Renal Injury Caused by ANCA-Associated Vasculitis","author":"Liang","year":"2017","journal-title":"Exp Ther Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2021.07.005","article-title":"The Neutrophil-to-Lymphocyte Ratio as a Marker of Vasculitis Activity, Severe Infection and Mortality in Anca-Associated Vasculitis: A Retrospective Study","volume":"41","author":"Fonseca","year":"2021","journal-title":"Nefrologia (Engl Ed)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12882-018-0992-4","article-title":"Neutrophil to Lymphocyte Ratio at Diagnosis Can Estimate Vasculitis Activity and Poor Prognosis in Patients With ANCA-Associated Vasculitis: A Retrospective Study","volume":"19","author":"Ahn","year":"2018","journal-title":"BMC Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00629-0","article-title":"The Association of Neutrophil-to-Lymphocyte Ratio With All-Cause Mortality in Chinese Patients With MPO-ANCA Associated Vasculitis","volume":"20","author":"Huang","year":"2020","journal-title":"Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2016.1259633","article-title":"Predictive Value of Neutrophil\/Lymphocyte Ratio in Renal Prognosis of Patients With Granulomatosis With Polyangiitis","volume":"39","author":"Kucuk","year":"2017","journal-title":"Ren Fail"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4125-y","article-title":"Platelet to Lymphocyte Ratio is Associated With the Current Activity of ANCA-Associated Vasculitis at Diagnosis: A Retrospective Monocentric Study","volume":"38","author":"Park","year":"2018","journal-title":"Rheumatol Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-019-0110-8","article-title":"Platelet\/Lymphocyte Ratio and Mean Platelet Volume in Patients With Granulomatosis With Polyangiitis","volume":"60","author":"Kucuk","year":"2019","journal-title":"Adv Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2882-5","article-title":"Liver Involvement in ANCA-Associated Vasculitis","volume":"35","author":"Willeke","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04704-3","article-title":"Clinical and Pathological Characteristics of ANA\/Anti-dsDNA Positive Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis","volume":"41","author":"Zhao","year":"2021","journal-title":"Rheumatol Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2143\/ACB.66.6.2062604","article-title":"The Clinical-Diagnostic Role of Antistreptolysin O Antibodies","volume":"66","author":"Geerts","year":"2011","journal-title":"Acta Clin Belg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of Creatinine Clearance From Serum Creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.051078","article-title":"Development of Comprehensive Disease Assessment in Systemic Vasculitis","volume":"84","author":"Flossmann","year":"2008","journal-title":"Postgraduate Med J"},{"key":"B25","article-title":"Anti-Streptolysin O Titer, Fifty-Five Years After Todd: A Reappraisal of Its Clinical Significance","volume":"67","author":"Aguzzi","year":"1988","journal-title":"Boll Ist Sieroter Milan"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1756-185X.2011.01668.x","article-title":"Serum Levels of Anti-Streptolysin O Antibodies: Their Role in Evaluating Rheumatic Diseases","volume":"15","author":"Ben-Chetrit","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10067-008-0844-x","article-title":"Clinical Manifestations Associated With High Titer of Anti-Streptolysin O in Behcet's Disease","volume":"27","author":"Oh","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B28","first-page":"48","article-title":"A Micromethod for the Serodiagnosis of Rheumatic Fever; Anti-Streptolysin-O Test","volume":"14","author":"RAPPAPORT","year":"1955","journal-title":"Acta Med Orient"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.137.7.2173","article-title":"Detection of C-Reactive Protein, Streptolysin O, and Anti-Streptolysin O Antibodies in Immune Complexes Isolated From the Sera of Patients With Acute Rheumatic Fever","volume":"137","author":"Gupta","year":"1986","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2016.08.004","article-title":"Prevalence of Rheumatic Heart Disease in Patients With Recurrent Tonsillitis and Elevated Anti-Streptolysin O Titers","volume":"89","author":"Sahin","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B31","first-page":"v","article-title":"Systemic Lupus Erythematosus: A Clinical Analysis","volume":"6","author":"Fries","year":"1975","journal-title":"Major Probl Intern Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101","article-title":"The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheumatol"},{"key":"B33","article-title":"ANA, DNA, and SLE","volume":"31","author":"Pinnas","year":"1977","journal-title":"Ariz Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.12.1422","article-title":"The Predictive Value of ANA and Anti-dsDNA Antibodies for Flares in SLE","volume":"40","author":"Bizzaro","year":"2001","journal-title":"Rheumatol (Oxford)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cei.12296","article-title":"Anti-dsDNA Antibodies as a Classification Criterion and a Diagnostic Marker for Systemic Lupus Erythematosus: Critical Remarks","volume":"179","author":"Rekvig","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/BF01409982","article-title":"Autoantibodies and Target Antigens in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides","volume":"16","author":"Savige","year":"1996","journal-title":"Rheumatol Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab158","article-title":"Lymphopenia at Diagnosis of ANCA-Vasculitis With Renal Involvement Is Correlated With Severity and Renal Prognosis","author":"Wacrenier","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12882-017-0754-8","article-title":"Anaemia is an Essential Complication of ANCA-Associated Renal Vasculitis: A Single Center Cohort Study","volume":"18","author":"Kawamura","year":"2017","journal-title":"BMC Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297918120155","article-title":"Alternate and Additional Functions of Erythrocyte Hemoglobin","volume":"83","author":"Kosmachevskaya","year":"2018","journal-title":"Biochem (Mosc)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-41769-7_14","article-title":"Hemoglobin: Structure, Function and Allostery","volume":"94","author":"Ahmed","year":"2020","journal-title":"Subcell Biochem"},{"key":"B42","article-title":"Hypoalbuminaemia in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Incidence and Significance","volume":"36","author":"Xu","year":"2018","journal-title":"Clin Exp Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.913667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T04:00:31Z","timestamp":1676001631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.913667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.913667"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.913667","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"article-number":"913667"}}